Blog
N-able (NABL) Beats Q2 Earnings and Revenue Estimates
N-able (NABL) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.14 per share a year ago. These figures are
D-Wave Quantum Inc. (QBTS) Reports Q2 Loss, Beats Revenue Estimates
D-Wave Quantum Inc. (QBTS) came out with a quarterly loss of $0.55 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.1 per share a year ago. These
Insulet (PODD) Surpasses Q2 Earnings and Revenue Estimates
Insulet (PODD) came out with quarterly earnings of $1.17 per share, beating the Zacks Consensus Estimate of $0.93 per share. This compares to earnings of $0.55 per share a year ago. These figures
Kimbell Royalty (KRP) Lags Q2 Earnings Estimates
Kimbell Royalty (KRP) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.11 per share a year ago. These
C4 Therapeutics, Inc. (CCCC) Reports Q2 Loss, Misses Revenue Estimates
C4 Therapeutics, Inc. (CCCC) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to a loss of $0.26 per share a year ago. These
Crocs (CROX) Q2 Earnings and Revenues Surpass Estimates
Crocs (CROX) came out with quarterly earnings of $4.23 per share, beating the Zacks Consensus Estimate of $4.01 per share. This compares to earnings of $4.01 per share a year ago. These figures are
Datadog (DDOG) Surpasses Q2 Earnings and Revenue Estimates
Datadog (DDOG) came out with quarterly earnings of $0.46 per share, beating the Zacks Consensus Estimate of $0.41 per share. This compares to earnings of $0.43 per share a year ago. These figures
Energy Transfer Q2 Earnings In Line With Estimates, Revenues Down Y/Y
Energy Transfer ET reported second-quarter 2025 adjusted earnings of 32 cents per unit, in line with the Zacks Consensus Estimate. The bottom line decreased 8.6% from the year-ago figure of 35
e.l.f. Beauty Q1 Earnings Beat Estimates, Sales Rise 9% Y/Y
e.l.f. Beauty, Inc. (ELF) reported results for the first-quarter fiscal 2026, wherein both top and bottom lines beat the Zacks Consensus Estimate. While net sales increased, earnings decreased from
Barrick Mining to Post Q2 Earnings: What's in the Cards for the Stock?
Barrick Mining Corporation B is slated to come up with second-quarter 2025 results before the opening bell on Aug. 11. The gold mining giant beat the Zacks Consensus Estimate for earnings in three
Apple Jumps 5.1% After $100 Billion U.S. Manufacturing Pledge
Apple Inc.'s AAPL shares soared 5.1% on Aug. 6, 2025, marking one of the most notable gains among major tech companies and driving a broader market rally. The sharp uptick came after a White House
Warner Bros. Discovery (WBD) Surpasses Q2 Earnings Estimates
Warner Bros. Discovery (WBD) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of a loss of $0.16 per share. This compares to a loss of $4.07 per share a year
SolarEdge Technologies (SEDG) Reports Q2 Loss, Beats Revenue Estimates
SolarEdge Technologies (SEDG) came out with a quarterly loss of $0.81 per share versus the Zacks Consensus Estimate of a loss of $0.82. This compares to a loss of $1.79 per share a year ago. These
Hyatt Hotels (H) Beats Q2 Earnings and Revenue Estimates
Hyatt Hotels (H) came out with quarterly earnings of $0.68 per share, beating the Zacks Consensus Estimate of $0.66 per share. This compares to earnings of $1.53 per share a year ago. These figures
Phathom Pharmaceuticals, Inc. (PHAT) Reports Q2 Loss, Tops Revenue Estimates
Phathom Pharmaceuticals, Inc. (PHAT) came out with a quarterly loss of $0.79 per share versus the Zacks Consensus Estimate of a loss of $0.76. This compares to a loss of $1.25 per share a year ago
Evergy Inc (EVRG) Q2 Earnings Surpass Estimates
Evergy Inc (EVRG) came out with quarterly earnings of $0.82 per share, beating the Zacks Consensus Estimate of $0.76 per share. This compares to earnings of $0.9 per share a year ago. These figures
Cogent Communications (CCOI) Reports Q2 Loss, Beats Revenue Estimates
Cogent Communications (CCOI) came out with a quarterly loss of $1.21 per share versus the Zacks Consensus Estimate of a loss of $0.93. This compares to a loss of $0.75 per share a year ago. These
Post Q2 Earnings, Is Chevron a Name to Watch or One to Chase?
Chevron Corporation’s CVX second-quarter earnings beat Zacks Consensus Estimate, but the broader narrative remains layered. While adjusted EPS of $1.77 topped the Zacks Consensus Estimate of $1.70
Viatris (VTRS) Tops Q2 Earnings and Revenue Estimates
Viatris (VTRS) came out with quarterly earnings of $0.62 per share, beating the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $0.69 per share a year ago. These figures
Warby Parker Inc. (WRBY) Q2 Earnings Match Estimates
Warby Parker Inc. (WRBY) came out with quarterly earnings of $0.08 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.06 per share a year ago. These figures are
US Foods (USFD) Tops Q2 Earnings Estimates
US Foods (USFD) came out with quarterly earnings of $1.19 per share, beating the Zacks Consensus Estimate of $1.14 per share. This compares to earnings of $0.93 per share a year ago. These figures
Martin Marietta (MLM) Surpasses Q2 Earnings Estimates
Martin Marietta (MLM) came out with quarterly earnings of $5.43 per share, beating the Zacks Consensus Estimate of $5.32 per share. This compares to earnings of $5.26 per share a year ago. These
Thermon Group (THR) Q1 Earnings and Revenues Miss Estimates
Thermon Group (THR) came out with quarterly earnings of $0.36 per share, missing the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.38 per share a year ago. These
Janus International Group, Inc. (JBI) Q2 Earnings and Revenues Beat Estimates
Janus International Group, Inc. (JBI) came out with quarterly earnings of $0.2 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to earnings of $0.21 per share a year
Aclaris Therapeutics (ACRS) Reports Q2 Loss, Beats Revenue Estimates
Aclaris Therapeutics (ACRS) came out with a quarterly loss of $0.13 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.15 per share a year ago. These figures are


